Psychiatric Nursing: Substance Use Disorders

Substance use disorders represent one of the most prevalent and complex challenges in modern healthcare, deeply intertwined with both physical and mental well-being. As a nurse, you are often on the front lines of identification and intervention, making your role pivotal in breaking the cycle of addiction.

Screening, Assessment, and Co-Occurring Disorders

The nursing process begins with accurate identification. Screening is the use of brief, validated tools to quickly determine if a patient is at risk for a substance use problem. Common instruments include the Alcohol Use Disorders Identification Test (AUDIT) and the Drug Abuse Screening Test (DAST). A positive screen necessitates a comprehensive assessment, which is a detailed exploration of the substance used, quantity, frequency, route of administration, duration of use, and the functional impact on the patient's life.

A critical component of this assessment is evaluating for co-occurring mental health disorders, formerly termed "dual diagnosis." Conditions like major depression, anxiety disorders, bipolar disorder, and post-traumatic stress disorder are exceptionally common among individuals with substance use disorders. You must determine whether the psychiatric symptoms are primary, substance-induced, or a combination. For instance, cocaine use can mimic manic symptoms, while alcohol withdrawal can produce severe anxiety. Failure to identify and treat co-occurring disorders significantly reduces the likelihood of sustained recovery from addiction.

Consider this vignette: Maria, a 38-year-old woman, is admitted for gastritis. During your assessment, she mentions using alcohol "to quiet her thoughts" and reports persistent low mood, anhedonia, and insomnia that predate her increased drinking. This history flags a potential co-occurring major depressive disorder alongside her alcohol use disorder, necessitating a coordinated psychiatric referral.

Managing Acute Withdrawal Syndromes

Managing withdrawal syndromes is a core medical-nursing responsibility to ensure patient safety. Withdrawal occurs when a dependent individual reduces or stops substance intake, leading to a predictable cluster of symptoms as the body attempts to achieve homeostasis without the drug.

Alcohol withdrawal can range from mild (tremors, anxiety, nausea) to severe and life-threatening. The timeline typically begins 6-12 hours after the last drink, with peak symptoms at 24-72 hours. You must vigilantly monitor for progression to alcohol withdrawal delirium (delirium tremens or DTs), characterized by profound confusion, agitation, hallucinations, tachycardia, hypertension, and hyperthermia. This is a medical emergency. Benzodiazepines (e.g., chlordiazepoxide, lorazepam) are the cornerstone of pharmacological management, using standardized protocols like the Clinical Institute Withdrawal Assessment for Alcohol (CIWA) scale to guide dosing and prevent under- or over-treatment.

Opioid withdrawal, while extremely distressing, is typically not life-threatening. Symptoms like piloerection ("cold turkey"), lacrimation, rhinorrhea, yawning, diaphoresis, nausea, vomiting, diarrhea, and muscle aches emerge within hours to days, depending on the opioid's half-life. Your role involves supportive care (hydration, antiemetics, antidiarrheals) and compassionate reassurance, often within a structured detoxification monitoring protocol. Detoxification is the medically supervised process of safely managing acute intoxication and withdrawal, but it is only the first step toward recovery, not a treatment for the disorder itself.

Pharmacotherapy and Medication Administration

Pharmacological interventions are essential for both acute stabilization and long-term recovery. Your knowledge of mechanism and administration is key.

For opioid use disorder, medications for opioid use disorder (MOUD) are evidence-based treatments. Buprenorphine is a partial opioid agonist that reduces cravings and withdrawal symptoms while having a ceiling effect on respiratory depression, enhancing safety. It is often combined with naloxone (as in Suboxone®) to deter misuse by injection. Naltrexone is an opioid antagonist that blocks the effects of opioids; it can be administered orally or as a monthly extended-release injectable (Vivitrol®). It is crucial to ensure the patient is fully detoxified from opioids before initiating naltrexone to avoid precipitating severe withdrawal.

For alcohol use disorder, naltrexone is used to reduce cravings and the pleasurable effects of alcohol. Acamprosate helps stabilize the brain's chemical balance disrupted by chronic alcohol use, reducing post-acute withdrawal symptoms like insomnia and anxiety. Disulfiram creates an aversive physical reaction (flushing, nausea, palpitations) if alcohol is consumed, acting as a psychological deterrent. Your nursing responsibilities include administering these medications, educating patients on their proper use and potential side effects, and assessing adherence and effectiveness.

Therapeutic Approaches and Continuum of Care

Beyond medical management, therapeutic interventions form the backbone of recovery. Motivational interviewing is a collaborative, person-centered counseling style designed to strengthen a person's own motivation for and commitment to change. Instead of confronting or arguing, you use open-ended questions, affirmations, reflective listening, and summarization to explore ambivalence and elicit "change talk." For example, asking, "What are some things you've enjoyed when you've had periods of less drinking in the past?" helps the patient build their own case for change.

Connecting patients to ongoing support is vital. You play a key role in facilitating 12-step program connections, such as Alcoholics Anonymous (AA) or Narcotics Anonymous (NA), by providing meeting schedules and, when possible, arranging for a volunteer to meet the patient. Simultaneously, harm reduction education is a pragmatic and compassionate public health strategy. This involves meeting patients where they are, without requiring abstinence as a precondition for support. Education may include teaching about safer injection practices to prevent infections like HIV and hepatitis C, carrying naloxone to reverse opioid overdoses, and strategies to avoid mixing substances. Harm reduction acknowledges that any positive step toward reduced risk is a success.

Common Pitfalls

1. Punitive Language and Stigmatizing Attitudes: Using labels like "addict" or framing substance use as a moral failure erodes trust and prevents honest disclosure. Correction: Use person-first language (e.g., "a person with a substance use disorder") and approach care with unconditional positive regard, recognizing addiction as a chronic brain disease.

1. Inadequate Assessment for Co-Occurring Disorders: Focusing solely on the substance use and overlooking symptoms of depression, trauma, or anxiety. Correction: Conduct a thorough psychosocial history and use standardized mental health screening tools as part of your initial nursing assessment.

1. Misunderstanding the Role of Detoxification: Viewing medical detox as "treatment" and discharging a patient without a concrete aftercare plan. Correction: Frame detox as the first step in stabilization. Begin discharge planning on admission, coordinating referrals to outpatient therapy, MOUD providers, and support groups.

1. Neglecting Family Education and Support: The disease of addiction affects the entire family system. Correction: Provide resources for family support groups like Al-Anon and educate family members on the nature of addiction, setting boundaries, and self-care to prevent burnout and enablement.

Summary

• Effective nursing care for substance use disorders hinges on systematic screening with tools like the AUDIT, followed by a comprehensive assessment that always includes evaluation for co-occurring mental health disorders.
• Acute withdrawal syndromes require vigilant monitoring and protocol-driven intervention, especially for life-threatening alcohol withdrawal delirium, while understanding that opioid withdrawal management is a gateway to long-term treatment.
• Medication administration is a core skill, encompassing knowledge of buprenorphine and naltrexone for opioid use disorder and naltrexone, acamprosate, and disulfiram for alcohol use disorder, all within a structured detoxification monitoring framework.
• Therapeutic communication should utilize motivational interviewing approaches to foster internal motivation, while practical support involves facilitating 12-step program connections and providing non-judgmental harm reduction education to meet patient needs at any stage of change.